Triple
T195378
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biogen |
E3807
|
entity |
| Predicate | hasProduct |
P3585
|
FINISHED |
| Object |
Aduhelm
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
|
E24938
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a2548debd48190ae3a06d6e65b53c6 |
elicitation | completed |
| NER | batch_69a25969425081908e178db8ba4631c2 |
ner | completed |
| NED1 | batch_69a3161cdc4c8190bc67683a1a5d39d9 |
ned_source_triple | completed |
| NED2 | batch_69a316d53594819095710388c11624eb |
ned_description | completed |
| NEDg | batch_69a31677d5c48190967cacd20fd6357a |
nedg | completed |
Created at: Feb. 28, 2026, 2:41 a.m.